Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.3 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |